PreveCeutical Medical Inc. PREV
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 73.65% | 20.34% | -28.88% | -121.34% | -96.86% |
| Total Depreciation and Amortization | 27.27% | 44.16% | 39.19% | 28.38% | 20.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -253.62% | -323.31% | -387.26% | 179.05% | 172.68% |
| Change in Net Operating Assets | -10.81% | -11.97% | 170.79% | 26.40% | 18.57% |
| Cash from Operations | -90.82% | -300.50% | -297.66% | -209.42% | -146.71% |
| Capital Expenditure | 100.00% | -200.00% | -61.54% | -225.00% | -285.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 204.28% | 204.25% | -- | -- | -- |
| Cash from Investing | 197.64% | 197.30% | 69.23% | -237.50% | -5,957.14% |
| Total Debt Issued | -32.17% | -96.10% | -78.01% | -69.90% | -64.92% |
| Total Debt Repaid | -51.00% | -131.81% | -131.81% | -36.30% | 3.06% |
| Issuance of Common Stock | 83.73% | 594.06% | 642.59% | 617.72% | 724.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 73.67% | 246.62% | 240.63% | 242.21% | 164.78% |
| Foreign Exchange rate Adjustments | 757.14% | 147.06% | -200.00% | -1,591.67% | 65.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 523.68% | 385.71% | -180.34% | 7,009.09% | 323.53% |